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Staphylococcus aureusAbstract Zuccagnia punctata Cav. (Fabaceae), a native plant from Argentina has been used tradi-
tionally as medicinal species. The aim of the study was to validate the antibiotic and anti-
inﬂammatory potential of Z. punctata organic extract (ZpE) and the major compounds; 20,40-dihy
droxy-30-methoxychalcone (DHMC), 20,40-dihydroxychalcone (DHC), 7-hydroxyﬂavanone (7-HF)
and 3,7-dihydroxyﬂavone (DHF); using an in vitro model. The antibiotic activity was determined
using a broth microdilution method and the minimum inhibitory concentration (MIC) was deter-
mined. The extract and the isolation compounds affect the normal growth of all assayed Staphylo-
coccus aureus strains. The MIC values for ZpE and isolated compounds were between 125 and
500 lg/mL and between 25 and 400 lg/mL, respectively, against all assayed strains. The inhibitory
effect of extract and isolated compounds on bioﬁlm formation and on pro-inﬂammatory enzymes
(sPLA2, COX-2, LOX) was analyzed. The compound DHC was the most active on sPLA2 while
DHF and DHMC showed the highest activity on LOX. Both the extract and pure compounds
except DHMC were active against COX-2. It can be concluded that the phytocomplex and the pure
compounds possessed antibiotic and anti-inﬂammatory activities under the conditions tested, and
could be a good alternative therapy for infective and inﬂammatory processes.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).cells and
2 G. Nun˜o et al.1. Introduction
Due to the difﬁculty of eradicating infections caused by Sta-
phylococcus aureus by its high capacity to develop antibiotic
resistance and virulence factors such as bioﬁlm, the optional
treatment with new antimicrobial agents is necessary. The phy-
tomedicine is a very interesting therapeutic alternative because
the plant extracts are multi-components that could act on mul-
tiple targets by different action mechanisms. Some countries
have begun to look at their locally available traditional medici-
nes as a means to drug new discovery.
Zuccagnia punctata Cav. (Fabaceae) is used for many
years in traditional medicine in Argentina (Cabrera, 1971)
as antimicrobial and anti-inﬂammatory (Toursarkissian,
1980). Antioxidant properties (Moran Vieyra et al., 2009),
antifungal activity (Svetaz et al., 2004, 2007; Agu¨ero et al.,
2010; Nun˜o et al., 2014; Moreno et al., 2015), antibacterial
activity against antibiotic resistant Gram-negative bacteria
(Zampini et al., 2005) and Streptococcus pneumoniae
(Zampini et al., 2012), activity on P-glycoprotein, a mem-
brane ABC transporter (Chieli et al., 2012), antigenotoxic
properties (Zampini et al., 2008), and antiulcer activity (De
la Rocha et al., 2003) were reported for Z. punctata ethanolic
extracts. Some bioactive phenolic constituents and major
components of Z. punctata ethanolic extracts were also
reported (Svetaz et al., 2004; Zampini et al., 2005; Agu¨ero
et al., 2010; Nun˜o et al., 2014).
The aim of the present work was to evaluate the effect of Z.
punctata extracts and their major chemical constituents on S.
aureus growth and virulence factor production as well as
pro-inﬂammatory enzyme inhibition in order to validate its
popular use. The toxicity (mutagenic and acute toxicity) was
also evaluated.2. Experimental
2.1. Extraction, isolation and compounds identification
The aerial parts of Z. punctata Cav. (voucher specimen N
605,935/LIL, Herbarium of ‘‘Fundacio´n Miguel Lillo”) was
collected from Monte region of Argentina. The plant samples,
were dried at 40 C grounded, macerated and extracted with
dichloromethane (DCM) (800 mL) to obtain a non-polar
extract of Z. punctata (ZpE). Then, ZpE was dried by rotary
evaporator to obtain the yield in dry weight. The extract was
resuspended in methanol and subjected to bio-guided fraction-
ation by Silica gel, Sephadex LH-20 and C18-column. The
fractions with antibiotic activity were analyzed with HPLC–
ESI-MS/MS for compounds identiﬁcation (Nun˜o et al.,
2014). The major compounds identiﬁed in these fractions were:
20,40-dihydroxy-30-methoxychalcone (DHMC), 20,40-dihydroxy
chalcone (DHC), 7-hydroxyﬂavanone (7-HF) and 3,7-
dihydroxyﬂavone (DHF). These compounds were also quanti-
ﬁed. A calibration curve was prepared using commercial stan-
dards to determine the relationship between the peak area and
concentration. The compounds concentration was expressed as
lg/mg of ZpE. Three replicates were used for all samples.
The antibacterial activity of each fraction was tested by
bioautographic and broth microdilution assays (Zampini
et al., 2009; CLSI, 2006).Please cite this article in press as: Nun˜o, G. et al., Eﬀect of Zuccagnia punctata Cav
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cells growth and biofilm formation
2.2.1. Microorganisms
Seven clinical isolates of S. aureus (F2, F5, F7, F8, F22, F23 and
F31) with different antibiotic resistance proﬁle obtained from
patients of the Hospital Nicola´s Avellaneda, San Miguel de
Tucuma´n, Tucuma´n, Argentina were used. A strain of Ameri-
can Type Culture Collection (ATCC 10231) was also used.
The inocula were prepared by adjusting the suspension turbidity
to match the 0.5 McFarland standards (108 CFU/mL).
2.2.2. Activity against planktonic cells
The activity of ZpE and pure compounds on S. aureus was
analyzed by a broth microdilution method according to the
CLSI reference M100S17 (CLSI, 2006). Assayed natural prod-
ucts were dissolved in 1% dimethyl sulfoxide (DMSO) to
obtain ﬁnal concentrations between 125 to 500 lg of dry
weight per mL (lg/mL) for the ZpE and between 25 to
400 lg/mL for each fraction and pure compound. The inocu-
lum (100 lL of Mueller Hinton broth containing
1  107 CFU/mL) was added to each well. Plates were incu-
bated at 37 C for 24 h. Aliquots of 10 lL of each well without
visible growth were inoculated onto the surface of Mueller
Hinton agar. The MIC and MBC values were determined.
2.2.3. Bioautographic assay
The Z. punctata aerial parts extracts were spotted on silica gel
TLC and developed using CHCl3:MeOH (9:1) as the mobile
phase. Then, the plates were covered with soft medium (BHI
with 0.6% agar) containing 105 CFU of a methicillin resistant
S. aureus (F7), incubated at 37 C for 16–20 h and revealed
with MTT solution (2.5 mg/mL) in PBS according to
Zampini et al. (2009).
2.2.4. Effect of natural product on biofilm formation and
metabolic activity
Z. punctata extract or isolated compounds (20 lL of 1/2 MIC)
were added to S. aureus (ATCC 25923 and F7 strains) suspen-
sion (180 lL of 1  108 cells/mL). The plates were incubated at
37 C during 24 h and then, the medium was aspirated, and
non-adherent cells were removed by washing with sterile
PBS. Ciproﬂoxacin (50 lg/mL) was used as positive control.
Finally, 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phe
nylamino)-carbonyl]-2H-tetrazolium hydroxide (XTT) or crys-
tal violet was added to determine the effect of natural product
on metabolic activity and bioﬁlm formation, respectively
(Gilabert et al., 2015).
2.2.5. Electron microscopy
S. aureus suspension (100 ll of 1  108 cells of F7 strain/mL)
was added to 100 lL of PBS or DHC at the MIC concentra-
tion. All tubes were incubated 24 h with stirring (500 rpm).
Then, were submitted to centrifugation for 5 min at 5000g
and the pellets were re-suspended in PBS.
2.2.5.1. Scanning electron microscopy (SEM). Untreated cells
and cells exposed to DHC were processed for electron micro-
scopy according to Thein et al. (2006) using 4% (v/v)
formaldehyde and 2% (v/v) glutaraldehyde in PBS, washed. (Fabaceae) extract on pro-inﬂammatory enzymes and on planktonic cells and
iences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.10.014
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tetroxide and dehydrated in alcohol (70% and 100%). Then,
the cells were treated with hexamethyldisilazane for 5 min.
The dehydrated samples were critical point-dried and then
coated with gold/palladium (40%/60%), before viewing using
a Zeiss-supra 55VP scanning electron microscope operated at
high vacuum at 15 kV.
2.2.5.2. Transmission electron microscopy (TEM). The treated
and non treated cells were placed in contact with 0.3%
terpinen-4-ol and then were ﬁxed over night with 2.5% of glu-
taraldehyde, and dehydrated in alcohol, propylene oxide and
araldite. The dehydrated samples were embedded in resin, sec-
tioned and stained according to Carson et al. (2002) before
examination using a Zeiss-EM 109 transmission electron
microscope operated at an accelerating voltage of 80 kV.
2.3. Effect of ZpE and selected major constituents upon pro-
inflammatory enzymes
2.3.1. Cyclooxygenase (COX) inhibition assay
The inhibitory activity of the samples was determined using
the COX inhibitor assay screening kit (Cayman Chemical
Co., Ann Arbor, MI, USA). Prostaglandins (PGs), which are
produced in the COX-2 reaction, were quantiﬁed via enzyme
immunoassay with a speciﬁc antibody that binds to major
PG compounds (D’Almeida et al., 2013). The natural products
at various concentrations in DMSO were tested. DMSO was
used in the control of 100% COX-2 activity. Nimesulide and
indomethacin were used as positive controls.
2.3.2. Lipoxygenase (LOX) inhibition assay
The assay was carried out by monitoring the LOX-mediated
transformation of linoleic acid into lipidic hydroperoxide at
234 nm. The reaction mixtures contained the following
reagents: soybean LOX-1 (0.9 mM), in borate buffer 0.2 M,
pH 9.0, tested natural products at various concentrations in
DMSO (25–200 lg/mL), and linoleic acid (50 lM). The
increase in absorbance was monitored for 4 min (D’Almeida
et al., 2013). The negative control was DMSO, and the positive
controls were naproxen and caffeic acid.
2.3.3. Phospholipase (sPLA2) inhibition assay
The substrate for sPLA2 were micelles of 1,2-di (hep-
tanoylthio) glycerophosphocholine (1.25 mM) with Triton X-
100 (0.3 mM) (D’Almeida et al., 2013). The substrate was dis-
solved in 10 mM Tris–HCl (pH 8) containing 10 mM CaCl2
and 100 mM KCl. Ten microlitre of sPLA2 (1 lg/mL) was
added to 50 lL of the buffer, 10 lL of 5,50- dithio-bis-2-
nitrobenzoic acid (DTNB) 10 mM and 5 lL of natural prod-
ucts in DMSO (10 lg/mL). The reaction was initiated with
150 lL of substrate and measuring absorbance at 415 nm for
20 min at 25 C. The negative control was DMSO, and the
positive control was naproxen.
2.4. Toxicity assay
2.4.1. General toxicity assay
The acute toxicity levels of ZpE and isolated compounds were
studied using Artemia salina as test organism (Svensson et al.,Please cite this article in press as: Nun˜o, G. et al., Eﬀect of Zuccagnia punctata Cav
bioﬁlm from Staphylococcus aureus. Toxicity studies. Saudi Journal of Biological Sc2005). Different concentrations of DHC (12.5–50 lg/mL),
DHMC, HF, DHF (50–200 lg/mL) or ZpE (125–500 lg/mL)
were used.
2.4.2. Mutagenicity test
The assays were performed according to Maron and Ames
(1983), with the Salmonella typhimurium TA98 and TA100
strain using different concentrations for ZpE and isolated
compounds (until 250 lg per plate). Negative and positive con-
trols were used simultaneously in each experiment. The posi-
tive control was 4-nitro-o-fenilendiamine (10 ll per plate,
1 mg/mL solution) for TA98 and TA100, and the negative con-
trol was DMSO (100 ll per plate). His + revertants were
counted after 48 h of incubation at 37 C. The test substance
was considered mutagenic if it reproducibly induced a twofold
increase in the number of mutants with at least one concentra-
tion, compared to the corresponding negative control (muta-
genicity relationship).
2.5. Statistical analysis
The data determined were expressed as the mean of three repli-
cate determinations and the values of relative standard devia-
tion (RSD) <10% were considered to meet the demands for
bioanalytical assay. The IC50 values were estimated by
linear/non-linear regression.
3. Results and discussion
3.1. Antimicrobial activity
In this paper we analyzed the antibiotic potency of Z. punctata
non-polar extract and major compounds previously isolated
(Nun˜o et al., 2014), against seven S. aureus strains isolated
from infections of patients from an hospital of Tucuma´n,
Argentina, and a collection strain.
The HPLC analysis showed that the contents of DHMC,
DHC, DHF and HF were 92.61, 109.4, 22.53 and 28.93 lg/
mg of ZpE, respectively; corresponding to 9.3, 10.9, 2.3,
2.9% of the extract weight.
It was shown that all assayed natural products affect the
normal growth of all clinical isolates of S. aureus and the
ATCC strains. The MIC values for ZpE were between 125
and 500 lg/mL and MBC values indicated that the extract
was active on 60% of strains. For the isolated compounds,
the MIC values were between 25 and 400 lg/mL and the
MBC values were between 50 and >400 lg/mL against all
strains assayed (Table 1).
The ZpE showed similar or greater potency as compared to
aqueous and hydroalcoholic extracts of the same and other
xerophyte plant species collected in arid environments of
Northwest Argentina against Gram positive and Gram
negative bacteria (Zampini et al., 2005, 2009, 2012). Isolated
compounds showed greater potency than the extract,
the order of reactivity for these latter was DHC>
DHF=HF>DHMC. Previously other authors reported
that OH groups of chalcones induce and enhance the antimi-
crobial activity, while the methoxy groups in the structure of
chalcones decrease or eliminate the antimicrobial activity
(Hatano et al., 2000). Moreover, the unsaturated chain of. (Fabaceae) extract on pro-inﬂammatory enzymes and on planktonic cells and
iences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.10.014
Table 1 Antibacterial activity of Z. punctata dichloromethanic extract (ZpE) and the major isolated compounds against antibiotic
sensible and resistant Staphylococcus aureus.
N strains ZpE DHC DHMC HF DHF Fenotype of clinical isolate
MIC/MBC (lg/mL)
2 250/R* 25/50 200/400 50/R* 25/400 Metr Oxar Genr Vans
5 125/500 25/100 200/200 200/R* 200/R* Metr Oxar
7 500/R* 25/100 200/200 200/200 200/R* Metr Oxar Genr
8 125/500 25/100 200/200 25/R* 25/400 Metr Oxar
22 250/R* 25/400 200/R* 25/R* 25/R* Metr Oxar Genr Vans
23 125/250 25/200 100/200 200/R* 200/R* Metr Oxar
31 125/250 100/200 200/200 200/R* 200/R* Metr Oxar Vans
ATCC 29213 125/250 50/50 200/200 200/R* 400/R* Control strain
ZpE: Z. punctata dichloromethanic extract. DHC: 20,40-dihydroxychalcone; DHMC: 20,40-dihydroxy-30-methoxychalcone. HF: 3-hydroxyﬂa-
vanone; DHF: 3,7-dihydroxyﬂavone. R*: resistent until 500 lg/mL of extract.
rResistant, sSusceptible; methicillin (Met), oxacillin (OXA), gentamycin (Gen), vancomycin (Van).
4 G. Nun˜o et al.DHC between rings A and B, was not a determinant of S. aur-
eus antimicrobial activity since the ﬂavone and ﬂavanone exhi-
bit similar antimicrobial activity. The compound DHC showed
a similar or higher inhibitory effect against S. aureus growth
than others hydroxylated chalcones on the ring B and ﬂavones
previously reports (20,4,60-trihydroxy-40- metoxychalcone, 3,5-
dihydroxy-6,7,8-trimetoxyﬂavona, apigenin and luteolin)
(Gibbons, 2004; Su¨zgec¸-Selc¸uk and Birtekso¨z, 2011; Yi et al.,
2008).
S. aureus treated with DHCwas observed by electron micro-
scopy (SEM and TEM) to conﬁrm the antimicrobial efﬁcacy of
the chalcone along with the morphological changes in the cell
appearance. Fig. 1 showed that the treated bacteria with MIC
values of DHC produce visible cellular aggregation, blebs on
the cellular surface and cytoplasmic coagulation. The formation
of blebs is an indicator of membrane damage because the totalFigure 1 Electron microscopy of Staphylococcus aureus cells (I, III
dihydroxychalcone. I and II SEM. III and IV TEM. Key to arrows:
membrane damage.
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poundDHCproduced cytoplasmic coagulation ofS. aureus cell,
evidenced by dark areas in the cells, as exempliﬁed by Fig. 1IV
(Codling et al., 2005). Stapleton et al. (2007) reported that a ﬂa-
vonol (epicatechin gallate) promoted staphylococcal cell aggre-
gation and increases cell-wall thickness.
3.2. Biofilm inhibition
Pathogenicity of microorganisms depends on the virulence fac-
tors developed to produce adhesion and invasion of host. Not
all antibiotics are able to inhibit these virulence factors, hence
the importance of ﬁnding alternative treatments. Therefore,
bioﬁlm formed by methicillin-resistant S. aureus have become
resistant to most available antimicrobial agents, including the
b-lactams (Lewis, 2005). For these reasons, it is interesting to) untreated (control) and (II, IV) treatment with 50 mg/mL 20,40-
A, aggregation; B, blebbing; CC, cytoplasmic coagulation; MD,
. (Fabaceae) extract on pro-inﬂammatory enzymes and on planktonic cells and
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Figure 2 The percent of bioﬁlm formation inhibition (A) and metabolism decrease (B) by Zuccagnia punctata (ZpE) and pure
metabolites. Methicillin resistant Staphylococcus aureus (MRSA) F7 strain and ATCC 25923 strain. DHC: 20,40-dihydroxychalcone;
DHMC: 20,40-dihydroxy-30-methoxychalcone. HF: 3-hydroxyﬂavanone; DHF: 3,7-dihydroxyﬂavone; ZpE: Z. punctata extract; CIP:
Ciproﬂoxacin. Data are presented as mean values ±SD (p < 0.05).
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mation by S. aureus. The effect of the samples was evaluated
on bioﬁlm formation by two strains of S. aureus a clinical iso-
late (F7 strain) and a collection strain (ATCC 25923), which
showed increased adherence to microplates. Fig. 2 shows that
the ZpE and the isolated compounds inhibit bioﬁlm formation
and reduce the metabolism of cells embedded in it. The DHC
was the most active pure compound in inhibiting S. aureus bio-
ﬁlm formation. Cushnie and Lamb (2011) reported inhibition
of bioﬁlm formation by ﬂavonoids. While De Lima Pimenta
et al. (2013) demonstrated bioﬁlm activity for other natural
and synthesized chalcones against Gram positive bacteria.
Furthermore, the present study is the ﬁrst report ofmedicinal
species extracts from arid environments of Argentina that inhi-
bit bioﬁlm formation of S. aureus. Vegetal extracts of Quercus
cerris L. (Fagaceae) showed similar S. aureus bioﬁlm inhibition
at the concentrations of 200 lg/mL (Hobby et al., 2012).
3.3. Anti-inflammatory properties of ZpE and selected major
constituents
In the inﬂammatory process, the membrane phospholipids are
hydrolyzed to produce arachidonic acid by phospholipasePlease cite this article in press as: Nun˜o, G. et al., Eﬀect of Zuccagnia punctata Cav
bioﬁlm from Staphylococcus aureus. Toxicity studies. Saudi Journal of Biological Scenzymes (PLAs) and then, this acid is metabolized through the
enzymes cyclooxygenases (COXs), and lipoxygenases (LOXs)
by different enzymatic pathways to produce prostaglandins,
thromboxanes and leucotrienes (D’Almeida et al., 2013).
In this work we investigated the inhibitory effect of ZpE
and isolated metabolites on pro-inﬂammatory enzymes
(sPLA2, LOX and COX-2).
For the secretory phospholipase A2 (sPLA2), DHC was the
most active compound follows by ZpE and DHMC, HF and
DHF (Table 2). The low inhibitory activity of ﬂavanones could
be due to the absence of the double bond between C2-C3 in the
ringB (Kim et al., 2004). The pure compoundsweremore potent
than the commercial anti-inﬂammatory drug, naproxen.
Lipoxygenases are the enzymes responsible for generating
hydroxy acids and leucotrienes from arachidonic acid. The
compounds DHF and DHMC showed the highest activity with
IC50 values of 57.8 and 63.4 lg/mL, respectively. The potency
of both compounds was similar to the caffeic acid used as con-
trol. Z. punctata extract also showed important inhibitory
activity. The ﬂavanone HF was the less active compound; this
is in agreement with Ribeiro et al. (2014) who reported that the
double bond between C2-C3 in the ring C is important for the
LOX inhibitory activity.. (Fabaceae) extract on pro-inﬂammatory enzymes and on planktonic cells and
iences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.10.014
Table 2 Inhibitory activity of Z. punctata extracts (ZpE) and the major isolated compounds against three pro-inﬂammatory enzymes.
Samples Inhibition (%) IC50 (lg/mL)
sPLA2 (10 lg/mL) LOX COX-2
ZpE 40.47 ± 2.00 69.30 ± 3.50 293.00 ± 20.50
DHC 60.50 ± 2.90 99.50 ± 3.00 1.72 ± 0.10
DHMC 38.18 ± 1.80 63.40 ± 3.10 –
HF 8.42 ± 0.40 155.00 ± 3.10 35.00 ± 2.40
DHF 2.70 ± 0.20 57.80 ± 2.90 25.50 ± 1.90
Naproxen 6.00 ± 0.40 8.14 ± 0.40 –
Nimesulide – – 0.39 ± 0.01
Indomethacin – – 0.28 ± 0.01
Caﬀeic acid – 57.5 ± 1.1 –
ZpE: Z. punctata dichloromethanic extract. DHC: 20,40-dihydroxychalcone; DHMC: 20,40-dihydroxy-30-methoxychalcone.; HF: 3-hydroxyﬂa-
vanone; DHF: 3,7-dihydroxyﬂavone. Data are presented as mean values ± SD (n= 3, p < 0.05).
6 G. Nun˜o et al.Cyclooxygenase-2 is a pivotal enzyme in inﬂammation, and
inhibitors of COX-2 are being continuously developed to
obtain safer anti-inﬂammatory drugs. As present in Table 2,
within the examined ﬂavonoids DHC showed the highest
COX-2 inhibitory activity with IC50 value of 1.72 lg/mL fol-
lowed by DHF, HF and ZpE. The DHMC was not active
against COX-2 at the tested concentrations (10–150 lg/mL).
The DHC showed similar activity to the synthetic anti-
inﬂammatory drugs assayed (indomethacin and nimesulide).
To our knowledge the compounds studied in this work were
for the ﬁrst time found as inhibitors of COX-2, LOX and
sPLA2 enzymes. However others chalcones, ﬂavones and ﬂa-
vanones were found to be inhibitors of these pro-
inﬂammatory enzymes (Kim et al., 2004).
Chalcone derivatives such as 3,4-dihydroxychalcone, 3,4,20-
trihydroxychalcone, 3,4,40-trihydroxychalcone and 3,4,2040-tet
rahydroxychalcone, inhibited LOX and COX activities, being
more active on LOX (Kim et al., 2004). In regard to the chal-
cones evaluated in this work, DHMC was more active on
LOX, while DHC was more potent on COX-2. However, weak
or no activity was observed on COX by Likhitwitayawuid
et al. (2002) for 4,40-dihydroxy-2,6-dimethoxydihydrochal
cone, 2,40-dihydroxy-4,6-dimethoxydihydrochalcone, 40-hydro
xy-2,4,6-trimethoxydihydrochalcone,4,6,40-trihydroxy-2-
methoxydihydrochalcone.
A fraction of Parastrephia lucida enriched in methoxy ﬂa-
vones strongly inhibited sPLA2 activity (D’Almeida et al.,
2013). The ﬂavone DHF at the concentration assayed in our
work was not active. On the other hand, Takano-Ishikawaa
et al. (2006) suggested that the 4-oxo functional group of the
C-ring is essential for the higher COX inhibition activities
and that the C2-C3 double-bond enhances the activity; this
could be the reason why DHF was more active than the HF.
Won et al. (2005) suggested that 20,4-dihydroxychalcone;
20,50-dihydroxy-indol-3-yl-chalcone; 20-hydroxy-2-thienylchal
cone; 20-hydroxy-3-tienylchalcone, 20-hydroxy-3,4-dichloro
chalcone and 3,5-di-ter-butyl-20,4,50-trihydroxychalcone were
potential anti-inﬂammatory agents.
3.4. Evaluation of acute toxicity
A. salina test is based on the possibility of a toxic compound to
kill A. salina larvae grown in the laboratory. None of the pure
compounds showed toxicity against A. salina at the concentra-
tions tested. Z. punctata extract showed LC50 (concentrationPlease cite this article in press as: Nun˜o, G. et al., Eﬀect of Zuccagnia punctata Cav
bioﬁlm from Staphylococcus aureus. Toxicity studies. Saudi Journal of Biological Scthat kills 50% of the A. salina larvae) value of 250 lg/mL,
while the positive control (sodium dichromate) showed a
LC50 value of 30 lg/mL.
3.5. Mutagenicity assay
In this study, the mutagenicity relationship resulted less than
1.5 for both the ZpE and the isolated compounds; indicating
that they were not mutagenic agents. Zampini et al. (2008)
did not ﬁnd genotoxicity of Z. punctata hidroalcoholic extract
and DHC using the in vitro comet assay test on human hep-
atoma HepG2 cells.
4. Conclusions
In summary, the ZpE (phytocomplex) and the pure com-
pounds were active against the S. aureus clinical isolated and
on three pro-inﬂammatory enzymes (sPLA2, LOX and
COX), so arachidonic acid metabolism could be inhibited at
different levels. The results showed that these natural products
could be a good alternative therapy for infective and inﬂam-
matory processes but in vivo assays are necessary to determine
the effectiveness of its use. The mutagenic effect absence is a
positive advance for determination of safety use of this medic-
inal plant species.Acknowledgements
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